Morgan Stanley Downgrades Incyte (INCY) to Underweight
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $120.77 -0.25%
Rating Summary:
17 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
17 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley downgraded Incyte (NASDAQ: INCY) from Equalweight to Underweight.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $19.18 yesterday.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $19.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- UBS Downgrades DiaSorin SpA (DIA:IM) (DSRLF) to Sell
- Stephens Downgrades WSFS Financial (WSFS) to Equal Weight
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
